Brilinta (ticagrelor) is a blood-thinning drug used in reducing the cardiovascular death and heart attack in patients with acute coronary syndromes (ACS). Brilinta prevents the new blood clots formation, thus maintains the blood flow in the body that helps reducing the risk of another cardiovascular event. There is a general increase in bleeding risk with associated with the use of Brilinta.
Brilinta allows the platelets in your blood from coagulating (clotting) to prohibit unwanted blood clots that can occur with certain blood vessel conditions or heart attack.
Brilinta lowers the risk of having stroke or any serious heart problems after undergone a heart attack or severe chest pain.